Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Resource Type
Article
Authors
Arisaka, T ; Asakura, T ; Azuma, N ; Fukuda, S ; Fukushima, Y ; Harada, N ; Inoue, S ; Ishida, H ; Ishii, H ; Ishikawa, S ; Jinnouchi, H ; Kaneko, S ; Kanno, K ; Kato, M ; Kato, Y ; Kawada, T ; Kim, H ; Kiyosue, A ; Matsuoka, O ; Miho, O ; Nakamoto, S ; Nakamura, S ; Nakanishi, S ; Nishimura, H ; Numata, A ; Ohama, T ; Okabe, T ; Okuguchi, F ; Osonoi, T ; Sasaki, T ; Seino, H ; Shin, K ; Shiraiwa, T ; Sugiura, T ; Wada, S ; Yamauchi, A ; Yabe, Daisuke ; Nakamura, Jiro ; Kaneto, Hideaki ; Deenadayalan, Srikanth ; Navarria, Andrea ; Gislum, Mette ; Inagaki, Nobuya
Source
In The Lancet Diabetes & Endocrinology May 2020 8(5):392-406
Subject
Primary Research Articles
Language
ISSN
2213-8587